New Study Makes Important Step Toward Treatment of Glioblastoma

A new study by the¬†Ivy Brain Tumor Center at Barrow Neurological Institute found that recently approved drug ribociclib may be an important part of treatment for glioblastoma, one of the deadliest cancers in the world….

Ivy Brain Tumor Center Offers Phase 0 Trials for Glioblastoma

The new Ivy Brain Tumor Center at Barrow Neurological Institute will offer Phase 0 trials for glioblastoma, the complex brain cancer that affected Sen. John McCain. Phase 0 trials seek to accelerate the drug approval…

Operating on Brain Gliomas by Detecting the ‘Glow’

Research by Barrow Neurological Institute physicians and University of Washington scientists on novel imaging technology for malignant brain tumors was published in the April issue of World Neurosurgery. The research was conducted by Drs. Evgenii…

Dr. Michael Lawton Discusses McCain’s Brain Cancer with Associated Press

The Associated Press spoke to Barrow President and CEO Dr. Michael Lawton about glioblastoma in an article describing Sen. John McCain’s brain cancer battle. McCain has maintained a busy schedule despite undergoing surgery, radiation therapy,…

About Barrow

Since our doors opened as a regional specialty center in 1962, we have grown into one of the premier destinations in the world for neurology and neurosurgery. Our experienced, highly skilled, and comprehensive team of neurological specialists can provide you with a complete spectrum of care–from diagnosis through outpatient neurorehabilitation–under one roof. Barrow Neurological Institute: Discover. Educate. Heal.